Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011;111(10 Pt 1):44-6.

[Noopept in the treatment of mild cognitive impairment in patients with stroke]

[Article in Russian]
A V Amelin, A Iu Iliukhina, A A Shmonin
  • PMID: 22500312
Clinical Trial

[Noopept in the treatment of mild cognitive impairment in patients with stroke]

[Article in Russian]
A V Amelin et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2011.

Abstract

Noopept is a neuroprotector and nootropics. Literature data revealed the treatment effect of noopept on mild cognitive impairment in patients with discirculatory encephalopathy. The present open prospective study included 60 patients with stroke treated with noopept during 12 months. Cognitive functions were assessed before and after treatment using neuropsychological tests. An analysis of MMSE scores and lateral and categorical associations revealed the significant improvement of cognitive functions after 2 months in patients of the main group compared to the controls. The global assessment of efficacy revealed the mild improvement in the main group while no changes were found in the control group. The results have demonstrated that noopept, used in dose 20 mg daily during 2 months, improves cognitive functions in stroke patients and has a high level of safety.

PubMed Disclaimer

Similar articles

See all similar articles

Publication types

LinkOut - more resources